These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26376863)

  • 1. Conditional depletion of intellectual disability and Parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and neurodegeneration.
    Dubos A; Castells-Nobau A; Meziane H; Oortveld MA; Houbaert X; Iacono G; Martin C; Mittelhaeuser C; Lalanne V; Kramer JM; Bhukel A; Quentin C; Slabbert J; Verstreken P; Sigrist SJ; Messaddeq N; Birling MC; Selloum M; Stunnenberg HG; Humeau Y; Schenck A; Herault Y
    Hum Mol Genet; 2015 Dec; 24(23):6736-55. PubMed ID: 26376863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the X-linked
    Rujano MA; Cannata Serio M; Panasyuk G; Péanne R; Reunert J; Rymen D; Hauser V; Park JH; Freisinger P; Souche E; Guida MC; Maier EM; Wada Y; Jäger S; Krogan NJ; Kretz O; Nobre S; Garcia P; Quelhas D; Bird TD; Raskind WH; Schwake M; Duvet S; Foulquier F; Matthijs G; Marquardt T; Simons M
    J Exp Med; 2017 Dec; 214(12):3707-3729. PubMed ID: 29127204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration.
    Hirose T; Cabrera-Socorro A; Chitayat D; Lemonnier T; Féraud O; Cifuentes-Diaz C; Gervasi N; Mombereau C; Ghosh T; Stoica L; Bacha JDA; Yamada H; Lauterbach MA; Guillon M; Kaneko K; Norris JW; Siriwardena K; Blasér S; Teillon J; Mendoza-Londono R; Russeau M; Hadoux J; Ito S; Corvol P; Matheus MG; Holden KR; Takei K; Emiliani V; Bennaceur-Griscelli A; Schwartz CE; Nguyen G; Groszer M
    J Clin Invest; 2019 Apr; 129(5):2145-2162. PubMed ID: 30985297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP6AP2 over-expression causes morphological alterations in the hippocampus and in hippocampus-related behaviour.
    Bracke A; Schäfer S; von Bohlen Und Halbach V; Klempin F; Bente K; Bracke K; Staar D; van den Brandt J; Harzsch S; Bader M; Wenzel UO; Peters J; von Bohlen Und Halbach O
    Brain Struct Funct; 2018 Jun; 223(5):2287-2302. PubMed ID: 29473106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of individual domains and the significance of shedding of ATP6AP2/(pro)renin receptor in vacuolar H(+)-ATPase biogenesis.
    Kinouchi K; Ichihara A; Sano M; Sun-Wada GH; Wada Y; Ochi H; Fukuda T; Bokuda K; Kurosawa H; Yoshida N; Takeda S; Fukuda K; Itoh H
    PLoS One; 2013; 8(11):e78603. PubMed ID: 24223829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colocalization of the (Pro)renin Receptor/Atp6ap2 with H+-ATPases in Mouse Kidney but Prorenin Does Not Acutely Regulate Intercalated Cell H+-ATPase Activity.
    Daryadel A; Bourgeois S; Figueiredo MF; Gomes Moreira A; Kampik NB; Oberli L; Mohebbi N; Lu X; Meima ME; Danser AH; Wagner CA
    PLoS One; 2016; 11(1):e0147831. PubMed ID: 26824839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP6AP2 functions as a V-ATPase assembly factor in the endoplasmic reticulum.
    Guida MC; Hermle T; Graham LA; Hauser V; Ryan M; Stevens TH; Simons M
    Mol Biol Cell; 2018 Sep; 29(18):2156-2164. PubMed ID: 29995586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel GLP1 Receptor Interacting Protein ATP6ap2 Regulates Insulin Secretion in Pancreatic Beta Cells.
    Dai FF; Bhattacharjee A; Liu Y; Batchuluun B; Zhang M; Wang XS; Huang X; Luu L; Zhu D; Gaisano H; Wheeler MB
    J Biol Chem; 2015 Oct; 290(41):25045-61. PubMed ID: 26272612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atp6ap2/(pro)renin receptor interacts with Par3 as a cell polarity determinant required for laminar formation during retinal development in mice.
    Kanda A; Noda K; Yuki K; Ozawa Y; Furukawa T; Ichihara A; Ishida S
    J Neurosci; 2013 Dec; 33(49):19341-51. PubMed ID: 24305829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atp6ap2/ (Pro) renin Receptor is Required for Laminar Formation during Retinal Development in Mice].
    Kanda A
    Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):787-98. PubMed ID: 26685483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A splice site mutation in ATP6AP2 causes X-linked intellectual disability, epilepsy, and parkinsonism.
    Gupta HV; Vengoechea J; Sahaya K; Virmani T
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1473-5. PubMed ID: 26467484
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).
    Korvatska O; Strand NS; Berndt JD; Strovas T; Chen DH; Leverenz JB; Kiianitsa K; Mata IF; Karakoc E; Greenup JL; Bonkowski E; Chuang J; Moon RT; Eichler EE; Nickerson DA; Zabetian CP; Kraemer BC; Bird TD; Raskind WH
    Hum Mol Genet; 2013 Aug; 22(16):3259-68. PubMed ID: 23595882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Atp6ap2/(Pro)renin Receptor Is Required for Normal Vacuolar H+-ATPase Function but Not for the Renin-Angiotensin System.
    Trepiccione F; Gerber SD; Grahammer F; López-Cayuqueo KI; Baudrie V; Păunescu TG; Capen DE; Picard N; Alexander RT; Huber TB; Chambrey R; Brown D; Houillier P; Eladari D; Simons M
    J Am Soc Nephrol; 2016 Nov; 27(11):3320-3330. PubMed ID: 27044666
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Binger KJ; Neukam M; Tattikota SG; Qadri F; Puchkov D; Willmes DM; Wurmsee S; Geisberger S; Dechend R; Raile K; Kurth T; Nguyen G; Poy MN; Solimena M; Muller DN; Birkenfeld AL
    Proc Natl Acad Sci U S A; 2019 Oct; 116(40):19983-19988. PubMed ID: 31527264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced gene dosage is a common mechanism of neuropathologies caused by ATP6AP2 splicing mutations.
    Edelman WC; Kiianitsa K; Virmani T; Martinez RA; Young JE; Keene CD; Bird TD; Raskind WH; Korvatska O
    Parkinsonism Relat Disord; 2022 Aug; 101():31-38. PubMed ID: 35779466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in ATP6AP2 cause autophagic liver disease in humans.
    Cannata Serio M; Rujano MA; Simons M
    Autophagy; 2018; 14(6):1088-1089. PubMed ID: 29388887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (Pro)renin receptor (ATP6AP2) depletion arrests As4.1 cells in the G0/G1 phase thereby increasing formation of primary cilia.
    Wanka H; Lutze P; Staar D; Peters B; Morch A; Vogel L; Chilukoti RK; Homuth G; Sczodrok J; Bäumgen I; Peters J
    J Cell Mol Med; 2017 Jul; 21(7):1394-1410. PubMed ID: 28215051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions of the (pro)renin receptor (Atp6ap2) at molecular and system levels: pathological implications in hypertension, renal and brain development, inflammation, and fibrosis.
    Hoffmann N; Peters J
    Pharmacol Res; 2021 Nov; 173():105922. PubMed ID: 34607004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies.
    Wendling O; Champy MF; Jaubert S; Pavlovic G; Dubos A; Lindner L; Jacobs H; Mark M; Combe R; Da Cruz IG; Luche H; Mudgett JS; Rosahl T; Sorg T; Malissen M; Reilly PT; Hérault Y
    Sci Rep; 2017 Aug; 7(1):9618. PubMed ID: 28851918
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Chen S; Venkatesan A; Lin YQ; Xie J; Neely G; Banerjee S; Bhat MA
    J Neurosci; 2022 Sep; 42(37):7016-7030. PubMed ID: 35944997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.